LL37 promotes angiogenesis: a potential therapeutic strategy for lower limb ischemic diseases
PurposeTo study the angiogenic capacity of antimicrobial peptide LL37 (cathelicidin antimicrobial peptide), explore its molecular mechanisms, and provide new ideas for treating lower limb ischemic diseases.MethodsLL37 was applied exogenously to human umbilical vein endothelial cells (HUVECs), and it...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1587351/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|